REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,554,890 | +12.1% | 15,250 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,386,530 | +139.3% | 15,250 | 0.0% | 0.01% | +133.3% |
| Q4 2022 | $579,348 | +51.3% | 15,250 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $383,000 | -17.3% | 15,250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $463,000 | -7.4% | 15,250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $500,000 | -50.3% | 15,250 | +52.5% | 0.00% | -50.0% |
| Q3 2021 | $1,006,000 | -28.9% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,415,000 | -11.3% | 10,000 | -37.5% | 0.01% | +50.0% |
| Q1 2021 | $1,596,000 | +115.1% | 16,000 | +166.7% | 0.00% | 0.0% |
| Q4 2020 | $742,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |